Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02873299 · ClinicalTrials.gov registry record · Early Phase 1
High-Frequency Repetitive Transcranial Magnetic Stimulation of the Right Dorsolateral Prefrontal Cortex in PTSD
A Early Phase 1 study, sponsored by United States Naval Medical Center, San Diego.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 37
- Enrollment target
NCT02873299: Completed Early Phase 1 study, sponsored by United States Naval Medical Center, San Diego.
NCT02873299 is a Early Phase 1 study that has completed, run by United States Naval Medical Center, San Diego. The registered enrollment target is 37 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (30% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02873299, a Early Phase 1 study, has completed, sponsored by United States Naval Medical Center, San Diego.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 37 participants
- Enrollment target
Study Summary
The purpose of this study is to compare two slightly different methods of transcranial magnetic stimulation (TMS) to treat Post Traumatic Stress Disorder (PTSD)
Primary Outcome
The CAPS is the gold-standard, semi-structured interview that corresponds to DSM-IV criteria for PTSD.
Interventions
- OTHER 10 Hz rTMS of the right dorsolateral prefrontal cortex
- OTHER 20 Hz rTMS of the right dorsolateral prefrontal cortex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2012-04 |
| Est. Completion | 2014-10 |
| Phase | Early Phase 1 |
What the finished NCT02873299 record still lists
NCT02873299 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (30% lower).
The record links to 0 conditions, and to 2 interventions - of which 10 Hz rTMS of the right dorsolateral prefrontal cortex is the first listed.
NCT02873299 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02873299 about?
NCT02873299 is a clinical study titled "High-Frequency Repetitive Transcranial Magnetic Stimulation of the Right Dorsolateral Prefrontal Cortex in PTSD". The purpose of this study is to compare two slightly different methods of transcranial magnetic stimulation (TMS) to treat Post Traumatic Stress Disorder (PTSD)
What is the current status of trial NCT02873299?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 37 participants. The study started on 2012-04. Estimated completion is 2014-10.
What interventions are being tested in trial NCT02873299?
The interventions under investigation include: 10 Hz rTMS of the right dorsolateral prefrontal cortex (OTHER), 20 Hz rTMS of the right dorsolateral prefrontal cortex (OTHER).
Who is sponsoring clinical trial NCT02873299?
This trial is sponsored by United States Naval Medical Center, San Diego, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02873299's enrollment target sits among peer trials
37 703rd of 2000 higher than 1,289 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia